# | Concept | Culture | Statement | Freq. |
---|---|---|---|---|
1 | clinical trials | Patient Advocacy Groups | Seen as a potential risk for participants and can be a barrier to access if not properly regulated | 1 |
2 | clinical trials | patient advocacy groups | Clinical trials must prioritize patient safety and informed consent, and should not exploit vulnerable populations. | 1 |